BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

641 related articles for article (PubMed ID: 19072422)

  • 1. Treatment strategies for recurrent and refractory Clostridium difficile-associated diarrhea.
    Stepan C; Surawicz CM
    Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):295-305. PubMed ID: 19072422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment strategies for C. difficile associated diarrhea.
    Stepan C; Surawicz CM
    Acta Gastroenterol Latinoam; 2007 Sep; 37(3):183-91. PubMed ID: 17955730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clostridium difficile associated diarrhea (CDAD)--hard to crack].
    Goldberg E; Bishara J
    Harefuah; 2009 Nov; 148(11):783-7, 791. PubMed ID: 20027984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clostridium difficile: changing epidemiology and new treatment options.
    Kuijper EJ; van Dissel JT; Wilcox MH
    Curr Opin Infect Dis; 2007 Aug; 20(4):376-83. PubMed ID: 17609596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridium difficile associated diarrhea: new rules for an old game.
    Verma P; Makharia GK
    Trop Gastroenterol; 2011; 32(1):15-24. PubMed ID: 21922851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New advances in Clostridium difficile infection: changing epidemiology, diagnosis, treatment and control.
    DuPont HL; Garey K; Caeiro JP; Jiang ZD
    Curr Opin Infect Dis; 2008 Oct; 21(5):500-7. PubMed ID: 18725800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridium difficile-associated diarrhea: risk factors, diagnostic methods, and treatment.
    Oldfield EC
    Rev Gastroenterol Disord; 2004; 4(4):186-95. PubMed ID: 15580153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on the changing epidemiology of Clostridium difficile-associated disease.
    McFarland LV
    Nat Clin Pract Gastroenterol Hepatol; 2008 Jan; 5(1):40-8. PubMed ID: 18174906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community-onset Clostridium difficile-associated diarrhoea not associated with antibiotic usage--two case reports with review of the changing epidemiology of Clostridium difficile-associated diarrhoea.
    Bauer MP; Goorhuis A; Koster T; Numan-Ruberg SC; Hagen EC; Debast SB; Kuijper EJ; van Dissel JT
    Neth J Med; 2008 May; 66(5):207-11. PubMed ID: 18490799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Established and potential risk factors for Clostridum difficile infection.
    Vaishnavi C
    Indian J Med Microbiol; 2009; 27(4):289-300. PubMed ID: 19736396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nosocomial diarrhea and Clostridium Difficile associated diarrhea in a Turkish University Hospital.
    Ergen EK; Akalin H; Yilmaz E; Sinirtaş M; Alver O; Heper Y; Ozakin C; Bakker D; Ener B; Mistik R; Helvaci S; Kuijper EJ
    Med Mal Infect; 2009 Jun; 39(6):382-7. PubMed ID: 19269761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridium difficile infection in cancer patients and hematopoietic stem cell transplant recipients.
    Chopra T; Alangaden GJ; Chandrasekar P
    Expert Rev Anti Infect Ther; 2010 Oct; 8(10):1113-9. PubMed ID: 20954878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The changing face of Clostridium difficile: what treatment options remain?
    Shen EP; Surawicz CM
    Am J Gastroenterol; 2007 Dec; 102(12):2789-92. PubMed ID: 18042108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridium difficile-associated disease. Epidemiology, morbidity, mortality, and methods for control.
    Miller MA
    Postgrad Med; 2001 Feb; 109(2 Suppl):39-42. PubMed ID: 19667556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027.
    Pépin J; Valiquette L; Gagnon S; Routhier S; Brazeau I
    Am J Gastroenterol; 2007 Dec; 102(12):2781-8. PubMed ID: 17900327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Past, present, and future therapies for Clostridium difficile-associated disease.
    Surowiec D; Kuyumjian AG; Wynd MA; Cicogna CE
    Ann Pharmacother; 2006 Dec; 40(12):2155-63. PubMed ID: 17148650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clostridium difficile-associated diarrhoea rates and global antibiotic consumption in five Quebec institutions from 2001 to 2004.
    Weiss K; Bergeron L; Bernatchez H; Goyette M; Savoie M; Thirion D
    Int J Antimicrob Agents; 2007 Oct; 30(4):309-14. PubMed ID: 17644347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridium difficile-associated diarrhea: resurgence with a vengeance.
    Oldfield EC
    Rev Gastroenterol Disord; 2006; 6(2):79-96. PubMed ID: 16699477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clostridium difficile-associated diarrhea outbreaks: the name of the game is isolation and cleaning.
    Beaulieu M; Thirion DJ; Williamson D; Pichette G
    Clin Infect Dis; 2006 Mar; 42(5):725; author reply 727-9. PubMed ID: 16447122
    [No Abstract]   [Full Text] [Related]  

  • 20. Rifamycin antibiotics for treatment of Clostridium difficile-associated diarrhea.
    Garey KW; Salazar M; Shah D; Rodrigue R; DuPont HL
    Ann Pharmacother; 2008 Jun; 42(6):827-35. PubMed ID: 18430792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.